Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211820 · ClinicalTrials.gov registry record
PET Imaging in Chronic Traumatic Encephalopathy
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 6
- Enrollment target
NCT02211820: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT02211820 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02211820 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Background: \- Chronic traumatic encephalopathy (CTE) is a brain disease caused in part by head injury. The brain changes from CTE can only be seen at autopsy. Researchers want to test a new brain scan to help diagnose CTE in living patients. Objective: \- To determine if a new type of brain scan can detect changes that occur in chronic traumatic encephalopathy. Eligibility: \- Adults age 18 60 with previous head injury or participation in certain sports. Design: * Participants will be screened with: * Physical exam * Blood and urine tests * Tests of thinking, mood, and memory * 30-minute magnetic resonance imaging (MRI) brain scan. A magnetic field and radio waves take pictures of the brain. Participants will lie on a table that slides into a metal cylinder. They will get earplugs for the loud knocking sounds. * Visit 1: Participants will have a 70-minute PET scan of the brain with a small amount of a radioactive chemical. That will be injected through an intravenous tube (catheter) in each arm. A catheter will also be put into an artery at the wrist or elbow. * Participants will lie on a bed that slides in and out of a donut-shaped scanner. A plastic mask may be molded to their face and head. Vital signs and heart activity will be checked before and during the scan. * Blood and urine will be taken before and after the scan. * Participants will be checked on by phone the next day. * Visit 2: Participants will repeat Visit 1 with a different chemical and no artery catheter. * Visit 3: Participants may have a spinal tap. Some fluid will be removed by needle between the bones in the back.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-08-01 |
| Est. Completion | 2016-10-12 |
What the finished NCT02211820 record still lists
NCT02211820 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02211820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02211820 about?
NCT02211820 is a clinical study titled "PET Imaging in Chronic Traumatic Encephalopathy". Background: \- Chronic traumatic encephalopathy (CTE) is a brain disease caused in part by head injury. The brain changes from CTE can only be seen at autopsy. Researchers want to test a new brain scan to help diagnose CTE in living patients. Objective: \- To determine if a new type of brain scan...
What is the current status of trial NCT02211820?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2014-08-01. Estimated completion is 2016-10-12.
Who is sponsoring clinical trial NCT02211820?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI